SIRT1 was determined to be an indicator of poor prognostic for gastric carcinoma [5], hepatocellular carcinoma [3], breast carcinoma [11], and diffuse large B cell lymphoma [10]. The gene discussed is SIRT1; the disease is hepatocellular carcinoma.